[HTML][HTML] Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled …
…, K Newbold, MA Tanay, F Adab, SJ Jefferies… - The lancet …, 2011 - thelancet.com
Background Xerostomia is the most common late side-effect of radiotherapy to the head and
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …
neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) …
[HTML][HTML] Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand
…, T Wood, L Jelley, T Jennings, S Jefferies… - Nature …, 2021 - nature.com
Stringent nonpharmaceutical interventions (NPIs) such as lockdowns and border closures are
not currently recommended for pandemic influenza control. New Zealand used these NPIs …
not currently recommended for pandemic influenza control. New Zealand used these NPIs …
[HTML][HTML] COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study
S Jefferies, N French, C Gilkison, G Graham… - The Lancet Public …, 2020 - thelancet.com
Background In early 2020, during the COVID-19 pandemic, New Zealand implemented
graduated, risk-informed national COVID-19 suppression measures aimed at disease elimination…
graduated, risk-informed national COVID-19 suppression measures aimed at disease elimination…
[HTML][HTML] Defining the tumour and target volumes for radiotherapy
NG Burnet, SJ Thomas, KE Burton, SJ Jefferies - Cancer Imaging, 2004 - ncbi.nlm.nih.gov
Radiotherapy is a localised treatment. The definition of tumour and target volumes for
radiotherapy is vital to its successful execution. This requires the best possible characterisation of …
radiotherapy is vital to its successful execution. This requires the best possible characterisation of …
[HTML][HTML] Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand
…, M Storey, J Hadfield, L Jelley, S Jefferies… - Nature …, 2020 - nature.com
New Zealand, a geographically remote Pacific island with easily sealable borders, implemented
a nationwide ‘lockdown’ of all non-essential services to curb the spread of COVID-19. …
a nationwide ‘lockdown’ of all non-essential services to curb the spread of COVID-19. …
A cancer research UK first time in human phase I trial of IMA950 (novel multipeptide therapeutic vaccine) in patients with newly diagnosed glioblastoma
…, O Al-Salihi, CJ Twelves, C McBain, S Jefferies… - Clinical cancer …, 2016 - AACR
Purpose: To perform a two-cohort, phase I safety and immunogenicity study of IMA950 in
addition to standard chemoradiotherapy and adjuvant temozolomide in patients with newly …
addition to standard chemoradiotherapy and adjuvant temozolomide in patients with newly …
[PDF][PDF] Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial
…, L Dunn, S Erridge, L Godfrey, S Jefferies… - Neuro …, 2020 - academic.oup.com
Background The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib potentiated
radiation and temozolomide (TMZ) chemotherapy in preclinical glioblastoma models but brain …
radiation and temozolomide (TMZ) chemotherapy in preclinical glioblastoma models but brain …
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase-II parallel non-randomized and observation study (EORTC 22042 …
…, A Lucas, T Veninga, A Pica, S Jefferies… - Radiotherapy and …, 2018 - Elsevier
Purpose The therapeutic strategy for non-benign meningiomas is controversial. The objective
of this study was to prospectively investigate the impact of high dose radiation therapy (RT) …
of this study was to prospectively investigate the impact of high dose radiation therapy (RT) …
[HTML][HTML] Genomic evidence of in-flight transmission of SARS-CoV-2 despite predeparture testing
…, P Shoemack, X Ren, M Storey, S Jefferies… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Since the first wave of coronavirus disease in March 2020, citizens and permanent
residents returning to New Zealand have been required to undergo managed isolation and …
residents returning to New Zealand have been required to undergo managed isolation and …
MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a …
…, L Schmidt, CL Faulkner, C Wragg, S Jefferies… - Neuro …, 2021 - academic.oup.com
Background The DNA repair protein O 6 -methylguanine-DNA methyltransferase (MGMT)
causes resistance of tumor cells to alkylating agents. It is a predictive biomarker in high-grade …
causes resistance of tumor cells to alkylating agents. It is a predictive biomarker in high-grade …
